FibroGen, Inc.FGENNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-138.26M
↓ 48% below average
Average (9y)
$-93.36M
Historical baseline
Range
High:$77.61M
Low:$-317.54M
CAGR
+23.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-138.26M | +56.5% |
| 2023 | $-317.54M | -71.9% |
| 2022 | $-184.67M | -64.3% |
| 2021 | $-112.42M | -244.9% |
| 2020 | $77.61M | +191.9% |
| 2019 | $-84.47M | -0.4% |
| 2018 | $-84.16M | -12.2% |
| 2017 | $-75.01M | -1381.0% |
| 2016 | $5.86M | +128.5% |
| 2015 | $-20.55M | - |